GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3501 - 3525 of 4050 in total
Antibody ▼ Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G92823JK
342
IgA Patient 2 3 mild
G93351GM
725
IgA Patient 2 3 mild
G94435QH
282
IgA Patient 2 3 mild
G94576MN
579
IgA Patient 2 3 mild
G96557TJ
389
IgA Patient 2 3 mild
G96865DJ
322
IgA Patient 2 3 mild
G96881BQ
272
IgA Patient 2 3 mild
G98068PA
501
IgA Patient 2 3 mild
G98240FC
441
IgA Patient 2 3 mild
G99603GB
505
IgA Patient 3 -180 mild
G00048MO
255
IgA Patient 3 -180 mild
G00051MO
251
IgA Patient 3 -180 mild
G00052MO
275
IgA Patient 3 -180 mild
G00053MO
255
IgA Patient 3 -180 mild
G00054MO
238
IgA Patient 3 -180 mild
G00057MO
390
IgA Patient 3 -180 mild
G00065MO
293
IgA Patient 3 -180 mild
G00066MO
319
IgA Patient 3 -180 mild
G00068MO
330
IgA Patient 3 -180 mild
G02557XE
247
IgA Patient 3 -180 mild
G02670IJ
281
IgA Patient 3 -180 mild
G03499BP
279
IgA Patient 3 -180 mild
G07483YN
269
IgA Patient 3 -180 mild
G08340FW
3386
IgA Patient 3 -180 mild
G08520NM
257

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024